|
|
||||||||











,
* Immunology Program, H. Lee Moffitt Comprehensive Cancer Center and Research Institute, and Departments of
Interdisciplinary Oncology and
Biochemistry, University of South Florida, Tampa, FL 33612
Previously we demonstrated that SHIP/ mice accept allogeneic bone marrow transplants (BMT) without significant acute graft-vs-host disease (GvHD). In this study we show that SHIP/ splenocytes and lymph node cells are poor stimulators of allogeneic T cell responses that cause GvHD. Intriguingly, SHIP/ splenocytes prime naive T cell responses to peptide epitopes, but, conversely, are partially impaired for priming T cell responses to whole Ag. However, dendritic cells (DC) purified from SHIP/ splenocytes prime T cell responses to allogeneic targets, peptide epitopes, and whole Ag as effectively as SHIP+/+ DC. These findings point to an extrinsic effect on SHIP/ DC that impairs priming of allogeneic T cell responses. Consistent with this extrinsic effect, we found that a dramatic expansion of myeloid suppressor cells in SHIP/ mice impairs priming of allogeneic T cells. These findings suggest that SHIP expression or its activity could be targeted to selectively compromise T cell responses that mediate GvHD and graft rejection.
This article has been cited by other articles:
![]() |
S. L. Highfill, R. M. Kelly, M. J. O'Shaughnessy, Q. Zhou, L. Xia, A. Panoskaltsis-Mortari, P. A. Taylor, J. Tolar, and B. R. Blazar Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of allopriming Blood, July 16, 2009; 114(3): 693 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Hazen, M. J. Smith, C. Desponts, O. Winter, K. Moser, and W. G. Kerr SHIP is required for a functional hematopoietic stem cell niche Blood, March 26, 2009; 113(13): 2924 - 2933. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Collazo, D. Wood, K. H. T. Paraiso, E. Lund, R. W. Engelman, C.-T. Le, D. Stauch, K. Kotsch, and W. G. Kerr SHIP limits immunoregulatory capacity in the T-cell compartment Blood, March 26, 2009; 113(13): 2934 - 2944. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kared, B. Leforban, R. Montandon, A. Renand, E. Layseca Espinosa, L. Chatenoud, Y. Rosenstein, E. Schneider, M. Dy, and F. Zavala Role of GM-CSF in tolerance induction by mobilized hematopoietic progenitors Blood, September 15, 2008; 112(6): 2575 - 2578. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Bishop, L. M. Sly, G. Krystal, and B. B. Finlay The Inositol Phosphatase SHIP Controls Salmonella enterica Serovar Typhimurium Infection In Vivo Infect. Immun., July 1, 2008; 76(7): 2913 - 2922. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. T. Paraiso, T. Ghansah, A. Costello, R. W. Engelman, and W. G. Kerr Induced SHIP Deficiency Expands Myeloid Regulatory Cells and Abrogates Graft-versus-Host Disease J. Immunol., March 1, 2007; 178(5): 2893 - 2900. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R Blazar and W. J Murphy Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD) Phil Trans R Soc B, September 29, 2005; 360(1461): 1747 - 1767. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |